Oorsprong van het eerstegraads netwerk van Sãbastien Desprez
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sãbastien Desprez via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AFFYMETRIX, INC. | Medical Specialties | Director of Finance/CFO | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Investor Relations Contact | |
PanAgora Asset Management, Inc.
 PanAgora Asset Management, Inc. Investment ManagersFinance PanAgora Asset Management, Inc. (PAM) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1989 and is a subsidiary of PanAgora Holdings, Inc., ultimately held by Power Corp. of Canada (TSE: POW) in Canada. PAM is the sponsor and investment manager for certain private unregistered investment pools, such as funds organized under US tax-qualified group trusts, domestic private funds organized as limited liability companies, and offshore private funds organized as Cayman Islands exempted companies. They also provide investment advisory services to institutional separate account clients. | Investment Managers | Analyst-Equity | |
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Biotechnology | Chief Executive Officer | |
| ABCAM PLC | Biotechnology | Director/Board Member Director of Finance/CFO | |
| ZYNERBA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
| University of Virginia | College/University | Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
| University of Bath | College/University | Undergraduate Degree | |
Unipart Group of Cos. Ltd.
 Unipart Group of Cos. Ltd. Miscellaneous Commercial ServicesCommercial Services Unipart Group of Cos. Ltd. engages in the provision of supply chain and logistics solutions. It serves the automotive, technology,retail, utilities, and rail industry. The company was founded on March 4, 1986 and headquartered in Cowley, the United kingdom. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
| Lehigh University | College/University | Masters Business Admin | |
| Wells College | College/University | Undergraduate Degree | |
| Trinity College Dublin | College/University | Undergraduate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Durham | College/University | Undergraduate Degree | |
| The University of Nottingham | College/University | Graduate Degree | |
| University of Sao Paulo | College/University | Doctorate Degree | |
| Escola Superior de Propaganda e Marketing | College/University | Masters Business Admin | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member | |
| University of Seville | College/University | Doctorate Degree | |
Amgen Ltd.
 Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
| Keller Graduate School of Management | College/University | Masters Business Admin | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
| Erivan K. Haub School of Business | College/University | Masters Business Admin | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Executive Officer | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| CABALETTA BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Pharmaceuticals Ltd.
 Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Huizhi Pharmaceutical (Dalian) Co., Ltd. is a pharmaceutical manufacturing company in China. It is a subsidiary compnay of Pfizer, Inc. The company was founded in 1980 and is headquartered in Beijing, CN. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ZAI LAB LIMITED | Biotechnology | President |
Statistieken
Internationaal
| Verenigde Staten | 34 |
| Verenigd Koninkrijk | 9 |
| Brazilië | 3 |
| China | 3 |
| Ierland | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Health Services | 3 |
| Finance | 2 |
Operationeel
| Director/Board Member | 46 |
| Independent Dir/Board Member | 25 |
| Corporate Officer/Principal | 24 |
| Director of Finance/CFO | 13 |
| Chief Tech/Sci/R&D Officer | 8 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter Thompson | 39 |
| Giles Kerr | 16 |
| John Furey | 9 |
| Rafael Amado | 9 |
| Michael R. Garone | 8 |
| William C. Roberts | 8 |
| Gavin Wood | 8 |
| Gwendolyn Binder-Scholl | 8 |
| Paul Stead | 6 |
| Cintia Piccina | 5 |
- Beurs
- Insiders
- Sãbastien Desprez
- Bedrijfsconnecties
